haemophilia society(the)
haemophilia society(the) Company Information
Company Number
01763614
Next Accounts
Dec 2024
Industry
Other social work activities without accommodation n.e.c.
Shareholders
-
Group Structure
View All
Contact
Registered Address
52b borough high street, london, SE1 1XN
Website
http://haemophilia.org.ukhaemophilia society(the) Estimated Valuation
Pomanda estimates the enterprise value of HAEMOPHILIA SOCIETY(THE) at £367.8k based on a Turnover of £795.2k and 0.46x industry multiple (adjusted for size and gross margin).
haemophilia society(the) Estimated Valuation
Pomanda estimates the enterprise value of HAEMOPHILIA SOCIETY(THE) at £0 based on an EBITDA of £-324.3k and a 4.62x industry multiple (adjusted for size and gross margin).
haemophilia society(the) Estimated Valuation
Pomanda estimates the enterprise value of HAEMOPHILIA SOCIETY(THE) at £2.6m based on Net Assets of £844k and 3.11x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Haemophilia Society(the) Overview
Haemophilia Society(the) is a live company located in london, SE1 1XN with a Companies House number of 01763614. It operates in the other social work activities without accommodation n.e.c. sector, SIC Code 88990. Founded in October 1983, it's largest shareholder is unknown. Haemophilia Society(the) is a mature, small sized company, Pomanda has estimated its turnover at £795.2k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Haemophilia Society(the) Health Check
Pomanda's financial health check has awarded Haemophilia Society(The) a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
4 Weak
Size
annual sales of £795.2k, make it larger than the average company (£456.7k)
£795.2k - Haemophilia Society(the)
£456.7k - Industry AVG
Growth
3 year (CAGR) sales growth of -5%, show it is growing at a slower rate (5.2%)
-5% - Haemophilia Society(the)
5.2% - Industry AVG
Production
with a gross margin of 66.4%, this company has a comparable cost of product (66.4%)
66.4% - Haemophilia Society(the)
66.4% - Industry AVG
Profitability
an operating margin of -41.5% make it less profitable than the average company (3.7%)
-41.5% - Haemophilia Society(the)
3.7% - Industry AVG
Employees
with 15 employees, this is similar to the industry average (13)
15 - Haemophilia Society(the)
13 - Industry AVG
Pay Structure
on an average salary of £45.4k, the company has a higher pay structure (£23.6k)
£45.4k - Haemophilia Society(the)
£23.6k - Industry AVG
Efficiency
resulting in sales per employee of £53k, this is more efficient (£38.3k)
£53k - Haemophilia Society(the)
£38.3k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Haemophilia Society(the)
- - Industry AVG
Creditor Days
its suppliers are paid after 42 days, this is slower than average (7 days)
42 days - Haemophilia Society(the)
7 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Haemophilia Society(the)
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 70 weeks, this is less cash available to meet short term requirements (247 weeks)
70 weeks - Haemophilia Society(the)
247 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 10.9%, this is a lower level of debt than the average (12.9%)
10.9% - Haemophilia Society(the)
12.9% - Industry AVG
HAEMOPHILIA SOCIETY(THE) financials
Haemophilia Society(The)'s latest turnover from March 2023 is £795.2 thousand and the company has net assets of £844 thousand. According to their latest financial statements, Haemophilia Society(The) has 15 employees and maintains cash reserves of £140.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 795,226 | 749,428 | 814,955 | 924,744 | 1,264,750 | 682,389 | 1,176,886 | 645,339 | 668,777 | 786,113 | 874,983 | 689,314 | 646,207 | 697,285 |
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | -324,612 | -402,743 | 155,046 | -41,272 | 192,177 | -95,744 | 439,378 | -8,157 | -122,282 | 147,892 | 305,236 | 64,762 | 38,939 | 69,352 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -324,612 | -402,743 | 155,046 | -41,272 | 192,177 | -95,744 | 439,378 | -8,157 | -122,282 | 147,892 | 305,236 | 64,762 | 38,939 | 69,352 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | -324,612 | -402,743 | 155,046 | -41,272 | 192,177 | -95,744 | 439,378 | -8,157 | -122,282 | 147,892 | 305,236 | 64,762 | 38,939 | 69,352 |
| Employee Costs | 680,645 | 623,896 | 464,436 | 489,973 | 516,157 | 382,443 | 362,998 | 262,773 | 299,447 | 344,289 | 305,508 | 295,455 | 305,641 | 267,001 |
| Number Of Employees | 15 | 13 | 9 | 11 | 12 | 10 | 10 | 7 | 5 | 7 | 7 | 7 | 8 | 7 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 5,172 | 9,189 | 11,084 | 15,609 | 10,795 | 8,478 | 19,245 | 27,881 | 40,666 | 40,664 | 11,045 | 14,222 | 20,263 | 9,872 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 729,754 | 1,026,391 | 1,395,552 | 1,183,943 | 1,150,088 | 1,103,787 | 567,558 | 524,558 | 717,216 | 782,233 | 573,324 | 300,412 | 207,592 | 95,071 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 734,926 | 1,035,580 | 1,406,636 | 1,199,552 | 1,160,883 | 1,112,265 | 586,803 | 552,439 | 757,882 | 822,897 | 584,369 | 314,634 | 227,855 | 104,943 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34,446 | 66,487 | 18,787 | 56,303 | 122,646 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 71,730 | 90,936 | 181,251 | 84,605 | 265,897 | 85,707 | 82,447 | 48,569 | 33,505 | 11,856 | 26,710 | 28,764 | 27,933 | 18,729 |
| Cash | 140,796 | 130,997 | 56,016 | 201,892 | 135,766 | 145,677 | 766,919 | 339,172 | 157,940 | 125,495 | 173,802 | 165,008 | 183,994 | 172,772 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 212,526 | 221,933 | 237,267 | 286,497 | 401,663 | 231,384 | 849,366 | 387,741 | 191,445 | 171,797 | 266,999 | 212,559 | 268,230 | 314,147 |
| total assets | 947,452 | 1,257,513 | 1,643,903 | 1,486,049 | 1,562,546 | 1,343,649 | 1,436,169 | 940,180 | 949,327 | 994,694 | 851,368 | 527,193 | 496,085 | 419,090 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 31,193 | 18,657 | 21,722 | 11,733 | 36,807 | 39,389 | 22,904 | 56,400 | 39,837 | 21,543 | 11,679 | 8,675 | 8,322 | 18,960 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 72,264 | 70,249 | 50,831 | 58,012 | 68,163 | 80,162 | 72,581 | 23,236 | 23,131 | 25,193 | 36,831 | 48,807 | 85,635 | 39,462 |
| total current liabilities | 103,457 | 88,906 | 72,553 | 69,745 | 104,970 | 119,551 | 95,485 | 79,636 | 62,968 | 46,736 | 48,510 | 57,482 | 93,957 | 58,422 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 103,457 | 88,906 | 72,553 | 69,745 | 104,970 | 119,551 | 95,485 | 79,636 | 62,968 | 46,736 | 48,510 | 57,482 | 93,957 | 58,422 |
| net assets | 843,995 | 1,168,607 | 1,571,350 | 1,416,304 | 1,457,576 | 1,224,098 | 1,340,684 | 860,544 | 886,359 | 947,958 | 802,858 | 469,711 | 402,128 | 360,668 |
| total shareholders funds | 843,995 | 1,168,607 | 1,571,350 | 1,416,304 | 1,457,576 | 1,224,098 | 1,340,684 | 860,544 | 886,359 | 947,958 | 802,858 | 469,711 | 402,128 | 360,668 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | 6,053 | 7,682 | 7,530 | 8,568 | 6,238 | 15,946 | 15,793 | 14,004 | 14,867 | 10,308 | 5,951 | 6,042 | 4,425 | 5,239 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -19,206 | -90,315 | 96,646 | -181,292 | 180,190 | 3,260 | 33,878 | 15,064 | -12,797 | -46,895 | 45,646 | -36,685 | -57,139 | 141,375 |
| Creditors | 12,536 | -3,065 | 9,989 | -25,074 | -2,582 | 16,485 | -33,496 | 16,563 | 18,294 | 9,864 | 3,004 | 353 | -10,638 | 18,960 |
| Accruals and Deferred Income | 2,015 | 19,418 | -7,181 | -10,151 | -11,999 | 7,581 | 49,345 | 105 | -2,062 | -11,638 | -11,976 | -36,828 | 46,173 | 39,462 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | 0 | 0 | 0 | 0 | -13,555 | -562,250 | -7,157 | 173,781 | 25,131 | |||||
| Change in Investments | -296,637 | -369,161 | 211,609 | 33,855 | 46,301 | 536,229 | 43,000 | -192,658 | -65,017 | 208,909 | 272,912 | 92,820 | 112,521 | 95,071 |
| cash flow from investments | 296,637 | 369,161 | -211,609 | -33,855 | -59,856 | -1,098,479 | -50,157 | 366,439 | 90,148 | |||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from financing | 0 | 0 | 0 | 0 | 41,301 | -20,842 | 40,762 | -17,658 | 60,683 | -2,792 | 27,911 | 2,821 | 2,521 | 291,316 |
| cash and cash equivalents | ||||||||||||||
| cash | 9,799 | 74,981 | -145,876 | 66,126 | -9,911 | -621,242 | 427,747 | 181,232 | 32,445 | -48,307 | 8,794 | -18,986 | 11,222 | 172,772 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 9,799 | 74,981 | -145,876 | 66,126 | -9,911 | -621,242 | 427,747 | 181,232 | 32,445 | -48,307 | 8,794 | -18,986 | 11,222 | 172,772 |
haemophilia society(the) Credit Report and Business Information
Haemophilia Society(the) Competitor Analysis
Perform a competitor analysis for haemophilia society(the) by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in SE1 area or any other competitors across 12 key performance metrics.
haemophilia society(the) Ownership
HAEMOPHILIA SOCIETY(THE) group structure
Haemophilia Society(The) has no subsidiary companies.
Ultimate parent company
HAEMOPHILIA SOCIETY(THE)
01763614
haemophilia society(the) directors
Haemophilia Society(The) currently has 12 directors. The longest serving directors include Mr Paul Sartain (Dec 2018) and Ms Jo Traunter (Nov 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Paul Sartain | England | 58 years | Dec 2018 | - | Director |
| Ms Jo Traunter | England | 57 years | Nov 2019 | - | Director |
| Mr Conan McIlwrath | England | 42 years | Nov 2019 | - | Director |
| Mr Gordon Dixon | England | 64 years | Nov 2019 | - | Director |
| Mrs Natalie Lawson | England | 54 years | Nov 2021 | - | Director |
| Mrs Amy Owen-Wyard | England | 36 years | Nov 2021 | - | Director |
| Mr Rayaz Chel | United Kingdom | 46 years | Nov 2021 | - | Director |
| Ms Susan Stretch | England | 46 years | Nov 2021 | - | Director |
| Ms Lisa Bagley | England | 54 years | Nov 2023 | - | Director |
| Ms Stacey McGeown | England | 36 years | Nov 2023 | - | Director |
P&L
March 2023turnover
795.2k
+6%
operating profit
-330.4k
0%
gross margin
66.4%
-11.14%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
844k
-0.28%
total assets
947.5k
-0.25%
cash
140.8k
+0.07%
net assets
Total assets minus all liabilities
haemophilia society(the) company details
company number
01763614
Type
Private Ltd By Guarantee w/o Share Cap
industry
88990 - Other social work activities without accommodation n.e.c.
incorporation date
October 1983
age
41
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2023
previous names
N/A
accountant
-
auditor
AZETS AUDIT SERVICES
address
52b borough high street, london, SE1 1XN
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
EVERSHEDS SUTHERLAND
haemophilia society(the) Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to haemophilia society(the).
haemophilia society(the) Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HAEMOPHILIA SOCIETY(THE). This can take several minutes, an email will notify you when this has completed.
haemophilia society(the) Companies House Filings - See Documents
| date | description | view/download |
|---|
